VRA Jumps 13.8% as EPS Growth Estimate Revised to 150%
Vera Bradley (VRA) led our EPS revision screener with a 13.8% gain to $5.85 after its next-year EPS growth estimate was revised from 86.4% to 150%. Grupo Televisa (TV) rose 11.8% to $2.47, while CoStar Group (CSGP) and BellRing Brands (BRBR) each gained over 10% as upward estimate revisions drove broad-to-sector-specific momentum.
| Ticker | Sector | Detected | EPS Revision | Gain Since Detection |
|---|---|---|---|---|
| VRA | Consumer Cyclical | 2026-10-09 | +63.6pp | +13.8% |
| TV | Communication Services | 2026-10-13 | N/A | +11.8% |
| CSGP | Real Estate | 2026-10-12 | N/A | +10.6% |
| BRBR | Consumer Defensive | 2026-10-09 | N/A | +10.3% |
| ALHC | Healthcare | 2026-10-09 | +6.6pp | +9.7% |
Why did VRA stock jump in October 2026?
VRA jumped 13.8% (from $5.14 to $5.85) after analysts revised its next-year EPS growth estimate from 86.4% to 150.0% on October 9.
The 63.6 percentage-point upward revision in the consumer-cyclical name was the strongest in our screener, signaling a sharp inflection in expected profitability. With no company-specific news in the window, the move reflects the market repricing the earnings trajectory and renewed sector interest in small-cap discretionary names.
VRA EPS revision history → · Screener snapshot from 2026-10-09 →
FAQ: VRA
Why did VRA stock jump?
VRA jumped 13.8% from $5.14 to $5.85 after its next-year EPS growth estimate was revised upward from 86.4% to 150.0% on October 9, 2026.
What is VRA's EPS growth estimate?
Vera Bradley's next-year EPS growth estimate was revised to 150.0%, up from 86.4% — a 63.6 percentage-point increase.
Is VRA a buy after the rally?
The upward EPS revision to 150% growth signals improving profitability expectations, but the rally has already priced in much of the near-term optimism, and no company-specific news has confirmed the estimate yet.
Why did TV stock jump in October 2026?
TV gained 11.8% (from $2.21 to $2.47) since October 13, when our screener flagged its next-year EPS growth estimate of 35.5%.
The communication-services name has no earnings-specific catalyst in the window, so the rally reflects improving sentiment toward Mexican telecom and media assets. The estimate revision served as the initial spark, with sector tailwinds reinforcing the move.
TV EPS revision history → · Screener snapshot from 2026-10-13 →
FAQ: TV
Why did TV stock surge recently?
TV stock surged 11.8% from $2.21 to $2.47 after our EPS revision screener detected its next-year EPS growth estimate at 35.5% on October 13, 2026.
What is TV's EPS growth estimate?
Grupo Televisa's next-year EPS growth estimate stands at 35.5%, as detected by our screen on October 13, 2026.
Is TV a buy after the rally?
The 35.5% EPS growth estimate supports a constructive view, but the 11.8% move has already occurred and no earnings-related news has validated the estimate yet.
Why did CSGP stock jump in October 2026?
CSGP rose 10.6% (from $29.21 to $32.31) since October 12, when our screener detected its next-year EPS growth estimate at 26.2%.
The real-estate data provider's revision reflects steady earnings momentum in commercial property analytics, and the price move confirms the market's growing confidence. With no earnings-specific news in the window, the rally aligns with broader real-estate sector stabilization.
CSGP EPS revision history → · Screener snapshot from 2026-10-12 →
FAQ: CSGP
Why did CSGP stock rise 10%?
CSGP rose 10.6% from $29.21 to $32.31 after our screen detected its next-year EPS growth estimate at 26.2% on October 12, 2026.
What is CSGP's EPS growth estimate?
CoStar Group's next-year EPS growth estimate was detected at 26.2% by our screener on October 12, 2026.
Is CSGP a buy after the recent gain?
The 26.2% growth estimate signals continued expansion, but without an earnings catalyst in the window, the 10.6% gain has already factored in much of the near-term revision.
Why did BRBR stock jump in October 2026?
BRBR jumped 10.3% (from $8.55 to $9.43) since October 9, when our screener spotted its next-year EPS growth estimate at 26.9%.
The consumer-defensive name, known for its protein shakes and nutrition products, has no earnings-specific news in the window. The move reflects the market rewarding resilient earnings expectations amid steady demand for functional foods.
BRBR EPS revision history → · Screener snapshot from 2026-10-09 →
FAQ: BRBR
Why did BRBR stock jump 10%?
BRBR jumped 10.3% from $8.55 to $9.43 after our EPS revision screener detected its next-year EPS growth estimate at 26.9% on October 9, 2026.
What is BRBR's EPS growth estimate?
BellRing Brands' next-year EPS growth estimate stands at 26.9%, as detected by our screen on October 9, 2026.
Is BRBR a buy after the rally?
The 26.9% EPS growth estimate supports ongoing profitability, but the 10.3% gain has already occurred without an earnings catalyst, so the stock may need further confirmation.
Why did ALHC stock jump in October 2026?
ALHC jumped 9.7% (from $7.55 to $8.28) after its next-year EPS growth estimate was revised from 129.4% to 136.1% on October 9.
The Medicare Advantage insurer announced on October 14 it will report Q3 2026 results on October 29, setting up a potential catalyst. Shares also recovered from a 20% drop earlier in the window tied to a Medicare Star Ratings downgrade, with the estimate revision helping steady sentiment ahead of earnings.
ALHC EPS revision history → · Screener snapshot from 2026-10-09 →
FAQ: ALHC
Why did ALHC stock jump?
ALHC jumped 9.7% from $7.55 to $8.28 after its next-year EPS growth estimate was revised from 129.4% to 136.1% on October 9, 2026.
What is ALHC's EPS growth estimate?
Alignment Healthcare's next-year EPS growth estimate was revised to 136.1%, up from 129.4% — a 6.6 percentage-point increase.
Is ALHC a buy after the rally?
The revised 136.1% EPS growth estimate is compelling, but the upcoming Q3 report on October 29 is a key catalyst, and the stock still faces overhang from the 2027 Medicare Star Ratings downgrade.
The breadth of today's gainers — from consumer cyclicals to healthcare — shows upward EPS revisions are being rewarded across sectors, even without accompanying news, suggesting the market is in a confirmation-seeking phase ahead of Q3 earnings.
How We Identify These Stocks
We track daily changes in forward EPS estimates across thousands of US equities. When a stock's next-year earnings growth estimate is revised upward — confirmed by improvement in current-year estimates — it enters our watchlist. The stocks above were flagged on their detection dates and have since delivered the strongest price returns among all detected stocks.
Explore today's full screener →